Ill. Consumers Say Walgreens Sold Toxic Blood Pressure Drug

Law360 (February 18, 2020, 4:40 PM EST) -- Walgreens failed to tell its customers it was selling a toxic drug to treat high blood pressure before the U.S. Food and Drug Administration found known and suspected carcinogens in the product and recalled it nationwide, a proposed class of Illinois consumers has claimed.

Consumer Harry Shanov claims in a Cook County Circuit Court suit filed Friday that Walgreens Boots Alliance Inc. materially misrepresented the safety of the recalled drug Valsartan, which contained unsafe levels of the probable carcinogen N-nitrosodimethylamine, or NDMA, and N-nitrosodiethylamine, or NDEA, a suspected human and known animal carcinogen. He alleged Walgreens knew about the drug's toxic nature...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!